Enveda Raises $311 Million in Series E Round
AI-driven natural-medicine biotech Enveda has raised $311 million in a Series E round, one of the larger late-stage biotech financings of the year.
Topic
Topic
AI-driven natural-medicine biotech Enveda has raised $311 million in a Series E round, one of the larger late-stage biotech financings of the year.
HIFI raised $37 million and Atum secured $13.5 million in new venture rounds, per Crypto News — over $50 million in fresh crypto…
Indian startups pulled in over $203 million this week, with EV maker Ultraviolette Automotive and spacetech firm GalaxEye among t…
Island raised $400 million and is mapping a path to an IPO, Axios reports, giving the cybersecurity firm a capital cushion to tim…
SK Hynix, the world's No. 2 memory chipmaker, has formed a dedicated venture capital arm focused on artificial intelligence, exte…
OpenAI investors have approached the company about a new funding round, CNBC reports, as backers move to fund the ChatGPT maker's…
ARK Invest tokenized its $1.3 billion ARK Venture Fund through Securitize, the first ARK fund onchain, exposing holdings in OpenA…
OMERS Ventures names Laura Lenz, a partner since 2019 and backer of Float, Hopper and Solink, as its third head in three years am…
Cyera raised $400 million from Goldman Sachs, the largest of eight New York City venture deals tracked by The Business Journals t…
AI House flew in VCs from Boston, New York, Colorado and the Bay Area as 25 Seattle startups pitched, with Friday Harbor underwri…
Island and Cyera each raised $400M in Evolution Equity-led rounds, topping a $2.3B week of U.S. megadeals spanning AI, biotech, n…